CLIFFORD RAPHIRI
Chairman
ANDY HALL
Chief Executive Officer
DORETTE NEETHLING
Chief Financial Officer
Leadership review
from our Chairman and CEO

Financial review


We are delighted to deliver this report following a successful financial year. Not only can we comment on an excellent set of financial results but also on encouraging progress made in the business, in line with our strategy.

View leadership review

We are very satisfied with this year’s results, in particular the increase of 20% in trading profit with growth in every division and the increase of 37% in headline earnings per share

View financial review


Operational review


Impala Platinum Holdings Limited

Over the counter
TURNOVER
R1 849m
(2016: R1 668m)
   
TRADING PROFIT
R342m
(2016: R310m)
TOP 10
BRANDS
TURNOVER

R1 086m
    Sales
 

OVERVIEW

OTC supplies medication for patients in South Africa’s private and public sectors as well as certain export markets, competing mainly in the self-medication category (Schedule 1 and Schedule 2) in the Pharmacy, but also in the FMCG channels with a complement of 91 premium and economy brands.

Over the counter
 

WERNER VAN RENSBURG
Managing Director

NATALIE ZAROUDOUKAS
Financial Director